לברסט

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

LETROZOLE 2.5 MG

Dostopno od:

RAFA LABORATORIES LTD

Koda artikla:

L02BG04

Farmacevtska oblika:

FILM COATED TABLETS

Pot uporabe:

PER OS

Izdeluje:

SIEGFRIED GENERICS ( MALTA) LTD

Terapevtska skupina:

LETROZOLE

Terapevtske indikacije:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Datum dovoljenje:

2012-04-01